Actively Recruiting

Phase 1
Phase 2
Age: 0Days - 3Months
All Genders
NCT07513038

Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia

Led by Boston Children's Hospital · Updated on 2026-04-06

20

Participants Needed

1

Research Sites

121 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Biliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-invasive diagnostic tests have limited sensitivity. Indocyanine Green (ICG) is a non-radioactive, fluorescent compound with several clinical applications including angiography for ophthalmologic testing, visualization during surgery, and measurement of liver function. After excitation with near infrared light (750-810 nm), ICG emits near infrared light at 850 nm, which can be detected by a special camera. ICG is taken up by the liver exclusively and excreted in the bile, where it is removed from the body in the stool. The hypothesis is that after injection of ICG, participants with biliary atresia will not have any fluorescence detected in the stool. Investigators aim to use ICG as a functional test of bile duct patency in participants with cholestasis being evaluated for biliary atresia.

CONDITIONS

Official Title

Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia

Who Can Participate

Age: 0Days - 3Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Infants younger than 3 months
  • Diagnosed with cholestasis, defined as direct bilirubin greater than 1
  • Scheduled for a diagnostic HIDA scan to evaluate for biliary atresia
Not Eligible

You will not qualify if you...

  • Kidney disease with estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73m2
  • Presence of grossly bloody stools
  • History of bowel surgery or bowel disease
  • History of allergic reaction to Indocyanine Green (ICG), iodine, or shellfish
  • Unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia | DecenTrialz